Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).
Saved in:
| Title: | Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). |
|---|---|
| Authors: | Møller-Bisgaard, S1,2 (AUTHOR) s.moeller.bisgaard@gmail.com, Ejbjerg, BJ2 (AUTHOR), Eshed, I3 (AUTHOR), Hørslev-Petersen, K4 (AUTHOR), Hetland, ML1,5 (AUTHOR), Jurik, AG6 (AUTHOR), Thomsen, H7 (AUTHOR), Torfing, T8 (AUTHOR), Stengaard-Pedersen, K9 (AUTHOR), Junker, P10 (AUTHOR), Krogh, NS11 (AUTHOR), Lottenburger, T12 (AUTHOR), Ellingsen, T10 (AUTHOR), Andersen, LS13 (AUTHOR), Skjødt, H1 (AUTHOR), Svendsen, AJ14 (AUTHOR), Tarp, U9 (AUTHOR), Hansen, IT9 (AUTHOR), Pødenphant, J13 (AUTHOR), Pedersen, JK10 (AUTHOR) |
| Source: | Scandinavian Journal of Rheumatology. Sep2017, Vol. 46 Issue 5, p335-345. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
